Story preview
LLY Reclaims $1,200 as Mounjaro and Zepbound Deliver $14.9B a Quarter — Buy Rating, $1,292 High in Sight
About this story
- Published
- Oct 7, 2026, 4:54 PM UTC
Continue reading on the publisher site for the full article.
Read on publisher →TradingNEWS
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee